{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:27:58Z","timestamp":1789140478471,"version":"build-2803163510"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/ftd.0b013e31827788c0","type":"journal-article","created":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T10:39:52Z","timestamp":1354012792000},"page":"48-53","source":"Crossref","is-referenced-by-count":30,"title":["Rapid Quantification of Gabapentin, Pregabalin, and Vigabatrin in Human Serum by Ultraperformance Liquid Chromatography With Mass-Spectrometric Detection"],"prefix":"10.1097","volume":"35","author":[{"given":"Abdel","family":"Chahbouni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Sinjewel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen C.","family":"G. den Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 M.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J.","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes I.","family":"Veldkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanora L.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(02)13011-7","article-title":". GABA and GABA receptors in the central nervous system and other organs.","volume":"213","author":"Watanabe","year":"2002","journal-title":"Int Rev Cytol"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":". Gabapentin receptor 2-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis.","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinthera.2007.01.013","article-title":". Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.","volume":"29","author":"Tassone","year":"2007","journal-title":"Clin Ther"},{"key":"R5-4-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.seizure.2005.11.005","article-title":"Pregabalin: a new antiepileptic drug for refractory epilepsy.","volume":"15","author":"Hamandi","year":"2006","journal-title":"Seizure"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpba.2010.02.036","article-title":". Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma.","volume":"53","author":"Mercolini","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"R8-4-20210129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0378-4347(97)00521-5","article-title":"Sensitive high-performance liquid chromatographic method with fluorometric detection for the simultaneous determination of gabapentin and vigabatrin in serum and urine.","volume":"705","author":"Wad","year":"1998","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"R9-4-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2710.2010.01243.x","article-title":". Rapid and validated fluorometric HPLC method for determination of gabapentin in human plasma and urine for clinical application.","volume":"37","author":"Yagi","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"R10-4-20210129","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.ftd.0000158874.54100.1a","article-title":"Analysis of pregabalin at therapeutic concentrations in human plasmaserum by reversed-phase HPLC.","volume":"27","author":"Berry","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1570-0232(04)00662-2","article-title":"Simultaneous high-performance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with o-phthaldialdehyde and fluorescence detection.","volume":"810","author":"Vermeij","year":"2004","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1365\/s10337-007-0440-2","article-title":". Determination of pregablin in human plasma using LC-MS-MS.","volume":"67","author":"Mandal","year":"2008","journal-title":"Chromatographia"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/chromsci\/47.10.868","article-title":"Validated LC-MS-MS method for the determination of gabapentin in human plasma: application to a bioequivalence study.","volume":"47","author":"Wattananat","year":"2009","journal-title":"J Chromatogr Sci"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jssc.200800461","article-title":". Simultaneous determination of three anticonvulsants using hydrophilic interaction LC-MS.","volume":"32","author":"Oertel","year":"2009","journal-title":"J Sep Sci"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1007669411738","article-title":". Bioanalytical method validationa revisit with a decade of progress.","volume":"12","author":"Shah","year":"2000","journal-title":"Pharm Res"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1081\/JLC-100101455","article-title":". Bioanalytical liquid chromatography method validation. A review of current practices and procedures.","volume":"23","author":"Rosing","year":"2000","journal-title":"J Liq Chrom Rel Technol"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MSMS.","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem"},{"key":"R20-4-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jchromb.2005.11.009","article-title":"Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis.","volume":"830","author":"Matuszewski","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R21-4-20210129","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":". Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31827788c0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:40:15Z","timestamp":1620952815000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201302000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31827788c0","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}